PTIXW
Protagenic Therapeutics, Inc.
Protagenic Therapeutics, Inc. (PTIXW) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 42.7, with 0/3 trend checks passing.
PTIXW with MA50 and MA200
Key levels & signals
Protagenic Therapeutics, Inc. (PTIXW) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $0.01, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 47.5% and below the 200-day moving average by 49.4%.
PTIXW currently has an RSI reading of 42.7, which leans a little softer than neutral. That does not automatically make the chart bearish, but it does suggest momentum is not especially strong right now.
For traders reviewing PTIXW next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.
About Protagenic Therapeutics, Inc.
Protagenic Therapeutics, Inc. is a biopharmaceutical company in its pre-clinical phase, dedicated to discovering and formulating treatments for neuropsychiatric and mood disorders that are related to stress. Its flagship compound, PT00114, is a laboratory-produced variant of teneurin carboxy-terminal associated peptide, a naturally occurring brain signaling peptide recognized for its capacity to moderate excessive stress reactions. The firm was established in 2016 and maintains its principal office in New York, New York.
PTIXW shares outstanding over time
Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.
Learn the indicators behind this page
More stock opportunities
Common questions about PTIXW
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.